Kopran Ltd.
| BSE: 524280 | Sector: Health care |
| NSE: KOPRAN | ISIN Code: INE082A01010 |
| BSE 00:00 | 23 Oct | 119.95 |
-2.65 (-2.16%) |
OPEN
121.05 |
HIGH
127.50 |
LOW
117.50 |
| NSE 00:00 | 23 Oct | 120.00 |
-2.50 (-2.04%) |
OPEN
122.00 |
HIGH
127.60 |
LOW
117.55 |
| OPEN | 121.05 |
| PREVIOUS CLOSE | 122.60 |
| VOLUME | 112798 |
| 52-Week high | 130.85 |
| 52-Week low | 16.15 |
| P/E | 32.95 |
| Mkt Cap.(Rs cr) | 519 |
| Buy Price | 119.95 |
| Buy Qty | 50.00 |
| Sell Price | 121.35 |
| Sell Qty | 3.00 |
Kopran Ltd. (KOPRAN) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Sun Pharma.Inds. | 484.35 | -1.30 | -0.27 | 3211.14 |
| Dr Reddy's Labs | 5015.90 | -7.70 | -0.15 | 2937.70 |
| Cipla | 756.85 | -0.50 | -0.07 | 2318.17 |
| Aurobindo Pharma | 783.05 | 0.60 | 0.08 | 1872.74 |
| Cadila Health. | 423.85 | -1.55 | -0.36 | 1412.90 |
| Divi's Lab. | 3067.25 | -18.40 | -0.60 | 1372.71 |
| Glenmark Pharma. | 485.00 | -1.85 | -0.38 | 1354.55 |
| Alkem Lab | 2598.15 | -19.95 | -0.76 | 1264.42 |
| Alembic Pharma | 973.70 | -37.90 | -3.75 | 969.40 |
| Torrent Pharma. | 2734.35 | 20.00 | 0.74 | 938.51 |
| P & G Health Ltd | 5062.45 | -29.80 | -0.59 | 838.72 |
| Lupin | 990.75 | -2.00 | -0.20 | 727.55 |
| Ipca Labs. | 2173.00 | 19.30 | 0.90 | 652.46 |
| Abbott India | 15637.25 | -179.55 | -1.14 | 592.93 |
| Fortis Health. | 126.55 | -1.65 | -1.29 | 513.33 |
| Pfizer | 5112.85 | 50.75 | 1.00 | 509.13 |
| Natco Pharma | 919.90 | 7.20 | 0.79 | 474.50 |
| Apollo Hospitals | 2075.10 | -26.10 | -1.24 | 470.30 |
| Granules India | 386.10 | -3.00 | -0.77 | 444.07 |
| Ajanta Pharma | 1598.85 | -35.90 | -2.20 | 441.13 |
Quick Links for Kopran:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
